The Special Experts Committee (SEC) deliberating on the Emergency Use Authorization (EUA) applications has submitted its recommendations to the Drugs Controller General of India (DCGI) on Saturday and now, the expert panel has given its nod for restricted emergency use of Bharat Biotech's vaccine candidate as well. Earlier, the Oxford vaccine 'Covishield' was approved by the panel and now, Covaxin developed by Bharat Biotech has also received the government expert team's nod. Both the vaccine now looks forward to receiving the final approval from the DCGI which is likely to be done tomorrow. Watch the full video to know more!
SUBSCRIBE NOW for more such videos ►[ Ссылка ]
For More Updates ► [ Ссылка ]
Like us on Facebook ► [ Ссылка ]
Follow us on Twitter ► [ Ссылка ]
Follow us on Instagram ► [ Ссылка ]
![](https://s2.save4k.org/pic/av4bsxAGs_k/maxresdefault.jpg)